These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1797 related articles for article (PubMed ID: 33734962)

  • 81. SARS-CoV-2 screening of asymptomatic women admitted for delivery must be performed with a combination of microbiological techniques: an observational study.
    Viñuela MC; De León-Luis JA; Alonso R; Catalán P; Lizarraga S; Muñoz P; Bouza E;
    Rev Esp Quimioter; 2020 Dec; 33(6):415-421. PubMed ID: 32945157
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy.
    Calcagno A; Ghisetti V; Emanuele T; Trunfio M; Faraoni S; Boglione L; Burdino E; Audagnotto S; Lipani F; Nigra M; D'Avolio A; Bonora S; Di Perri G
    Emerg Infect Dis; 2021 Jan; 27(1):303-5. PubMed ID: 33021927
    [TBL] [Abstract][Full Text] [Related]  

  • 84. How kids' immune systems can evade COVID.
    Nogrady B
    Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982
    [No Abstract]   [Full Text] [Related]  

  • 85. Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score.
    Sen SR; Sanders EC; Gabriel KN; Miller BM; Isoda HM; Salcedo GS; Garrido JE; Dyer RP; Nakajima R; Jain A; Caldaruse AM; Santos AM; Bhuvan K; Tifrea DF; Ricks-Oddie JL; Felgner PL; Edwards RA; Majumdar S; Weiss GA
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910993
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.
    Ferreira VH; Chruscinski A; Kulasingam V; Pugh TJ; Dus T; Wouters B; Oza A; Ierullo M; Ku T; Majchrzak-Kita B; Humar ST; Bahinskaya I; Pinzon N; Zhang J; Heisler LE; Krzyzanowski PM; Lam B; Lungu IM; Manase D; Pace KM; Mashouri P; Brudno M; Garrels M; Mazzulli T; Cybulsky M; Humar A; Kumar D
    PLoS One; 2021; 16(2):e0247258. PubMed ID: 33592074
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital.
    Lapić I; Rogić D; Šegulja D; Kralik Oguić S; Knežević J
    Croat Med J; 2020 Dec; 61(6):485-490. PubMed ID: 33410294
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prevalence of SARS-CoV-2 Infection Among Health Care Workers in a Tertiary Community Hospital.
    Jeremias A; Nguyen J; Levine J; Pollack S; Engellenner W; Thakore A; Lucore C
    JAMA Intern Med; 2020 Dec; 180(12):1707-1709. PubMed ID: 32780100
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein.
    Horndler L; Delgado P; Abia D; Balabanov I; Martínez-Fleta P; Cornish G; Llamas MA; Serrano-Villar S; Sánchez-Madrid F; Fresno M; van Santen HM; Alarcón B
    EMBO Mol Med; 2021 Mar; 13(3):e13549. PubMed ID: 33471406
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
    Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
    PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.
    Alserehi HA; Alqunaibet AM; Al-Tawfiq JA; Alharbi NK; Alshukairi AN; Alanazi KH; Bin Saleh GM; Alshehri AM; Almasoud A; Hashem AM; Alruwaily AR; Alaswad RH; Al-Mutlaq HM; Almudaiheem AA; Othman FM; Aldakeel SA; Abu Ghararah MR; Jokhdar HA; Algwizani AR; Almudarra SS; Albarrag AM
    Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115273. PubMed ID: 33296851
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria.
    Egger M; Bundschuh C; Wiesinger K; Bräutigam E; Berger T; Clodi M; Dieplinger B
    Clin Chem Lab Med; 2021 May; 59(6):e231-e234. PubMed ID: 33554543
    [No Abstract]   [Full Text] [Related]  

  • 93. Severe Acute Respiratory Syndrome Coronavirus-2 Infections in Critical Care Staff: Beware the Risks Beyond the Bedside.
    El Bouzidi K; Pirani T; Rosadas C; Ijaz S; Pearn M; Chaudhry S; Patel S; Sureda-Vives M; Fernandez N; Khan M; Cherepanov P; McClure MO; Tedder RS; Zuckerman M;
    Crit Care Med; 2021 Mar; 49(3):428-436. PubMed ID: 33512941
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India.
    Selvaraju S; Kumar MS; Thangaraj JWV; Bhatnagar T; Saravanakumar V; Kumar CPG; Sekar K; Ilayaperumal E; Sabarinathan R; Jagadeesan M; Hemalatha MS; Murhekar MV;
    Emerg Infect Dis; 2021 Feb; 27(2):586-589. PubMed ID: 33496222
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Long-term clinical and serological follow-up of paediatric patients infected by SARS-CoV-2.
    Calitri C; Fantone F; Benetti S; Lupica MM; Ignaccolo MG; Banino E; Viano A; Pace M; Castella A; Gaido F; Garofalo F; AslTorinoTre Study Group Paediatric Covid
    Infez Med; 2021 Jun; 29(2):216-223. PubMed ID: 34061786
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor.
    Funabashi R; Miyakawa K; Yamaoka Y; Yoshimura S; Yamane S; Jeremiah SS; Shimizu K; Ozawa H; Kawakami C; Usuku S; Tanaka N; Yamazaki E; Kimura H; Hasegawa H; Ryo A
    J Mol Cell Biol; 2021 Dec; 13(10):763-766. PubMed ID: 34165565
    [No Abstract]   [Full Text] [Related]  

  • 97. Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody.
    Tian X; Mo C; Zhou L; Yang Y; Zhou Z; You A; Fan Y; Liu W; Li X; Zhou R
    Virus Res; 2021 Jul; 300():198445. PubMed ID: 33961897
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK.
    Amirthalingam G; Whitaker H; Brooks T; Brown K; Hoschler K; Linley E; Borrow R; Brown C; Watkins N; Roberts DJ; Solomon D; Gower CM; de Waroux OLP; Andrews NJ; Ramsay ME
    Emerg Infect Dis; 2021 Jul; 27(7):1795-1801. PubMed ID: 34152947
    [TBL] [Abstract][Full Text] [Related]  

  • 99. SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan.
    Yoshihara T; Ito K; Zaitsu M; Chung E; Aoyagi I; Kaji Y; Tsuru T; Yonemura T; Yamaguchi K; Nakayama S; Tanaka Y; Yurino N; Koyanagi H; Matsuki S; Urae R; Irie S
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33916399
    [TBL] [Abstract][Full Text] [Related]  

  • 100. SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020.
    Akinbami LJ; Vuong N; Petersen LR; Sami S; Patel A; Lukacs SL; Mackey L; Grohskopf LA; Shehu A; Atas J
    Emerg Infect Dis; 2020 Dec; 26(12):2863-2871. PubMed ID: 32956614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 90.